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Objective: To investigate the prevalence and pattern of radiographic osteoarthritis (ROA) of the hand
joints and its association with self reported hand pain and disability.
Methods: Baseline data on a population based study (age >55 years) were used (n = 3906). Hand ROA
was defined as the presence of Kellgren–Lawrence grade >2 radiological changes in two of three groups
of hand joints in each hand. The presence of hand pain during the previous month was defined as hand
pain. The health assessment questionnaire was used to measure hand disability.
Results: 67% of the women and 54.8% of the men had ROA in at least one hand joint. DIP joints were
affected in 47.3% of participants, thumb base in 35.8%, PIP joints in 18.2%, and MCP joints in 8.2% (right
or left hand). ROA of other joint groups (right hand) co-occurred in 56% of DIP involvement, 88% of PIP
involvement, 86% of MCP involvement, and 65% of thumb base involvement. Hand pain showed an odds
ratio of 1.9 (1.5 to 2.4) with the ROA of the hand (right). Hand disability showed an odds ratio of 1.5 (1.1
to 2.1) with ROA of the hand (right or left).
Conclusions: Hand ROA is common in the elderly, especially in women. Co-occurrence of ROA in different
joint groups of the hand is more common than single joint disease. There is a modest to weak association
between ROA of the hand and hand pain/disability, varying with the site of involvement.
O
steoarthritis is the most common form of arthritis
among the elderly and one of the leading musculo-
skeletal causes of disability in Western countries.1 2
The hand is often involved in patients suffering from
osteoarthritis. The estimated prevalence of osteoarthritis in
the hand varies depending on the definition. Although point
prevalence of radiographic osteoarthritis (ROA) is reported to
be as high as 29–76% in population based studies, the
prevalence of symptomatic hand osteoarthritis is much lower,
with a point prevalence of between 4% and 6.2%.3–5 The
pattern of hand joint involvement found among affected
individuals remains contentious. In addition, despite
advances in our understanding of the disease, a discrepancy
remains between structural markers of pathology and the
clinical syndrome of osteoarthritis typified by joint pain and
disability.6–8 Zhang et al reported that symptomatic hand
osteoarthritis limited several daily functional activities in the
Framingham study.9 Jones et al reported a modest association
between the presence of ROA and hand pain or disability in a
population with diagnosis of hand osteoarthritis.10
However, whether the association between ROA and hand
pain or disability differentiates between different hand joint
groups has not been evaluated. Our aim in this study was to
explore the prevalence and pattern of ROA in the hand joints,
and to investigate the association between ROA of different
joints in the hand and self reported hand pain and/or
disability in an open population.
METHODS
Study population
For this study we used cross sectional baseline data from the
Rotterdam study, a population based cohort. The medical
ethics committee of the Erasmus Medical Centre approved
the study, and written informed consent was obtained from
all participants.
The baseline measurements were conducted between 1990
and 1993. The complete study design has been described
previously.11 All inhabitants of a suburb of Rotterdam aged
55 years and older were invited to participate. In all, 7983
participants were examined (a response rate of 78%). At
baseline, trained interviewers undertook an extensive
home interview on demographic characteristics, medical
history, risks factors for chronic diseases, and therapeutic
drug use. Radiographs were taken at the research centre
at baseline. For feasibility reasons we scored hand radio-
graphs for ROA on only 3906 of the participants, including all
those who were available for follow up six years later
(n = 3585).
Radiographic scoring
Two trained assessors (S Dahaghin and U Cimen), who were
blinded to the clinical and demographic data, scored standard
anteroposterior radiographs of both hands in 2002.
Radiographs were scored for six individual radiographic
features of osteoarthritis in the five distal interphalangeal
(DIP) joints, four proximal interphalangeal (PIP) joints, five
metacarpophalangeal (MCP) joints, the first carpometacarpal
joint (CMC1), and the trapezioscaphoid joint (TS).
Osteophytes were differentiated into three grades (small,
moderate, large), while joint space narrowing, sclerosis, cysts,
lateral deformity, and cortical collapse were scored as either
present or absent. Lateral deformity was defined as malalign-
ment of at least 15˚ (modified Kallman score).12 Each joint
was graded for overall ROA using a modified Kellgren–
Lawrence (K-L) grade scaled from 0 to 4 (appendix 1).13 ROA
for each joint was defined as a K-L grade of >2. DIP, PIP,
Abbreviations: CMC1/TS, first carpometacarpal and trapezioscaphoid
joint; DIP, distal interphalangeal joint; K-L, Kellgren–Lawrence
radiological grade; MCP, metacarpophalangeal joint; PIP, proximal
interphalangeal joint; ROA, radiographic osteoarthritis
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MCP, and CMC1/TS joint groups were defined as positive if at
least one joint of the group had a K-L grade of>2. Hand ROA
was defined as the presence of a K-L grade of >2 in two of
three groups of hand joints (DIP, PIP, and CMC1/TS) of each
hand. The same definition was used for the cut off point K-L
>3 or K-L = 4.
To investigate the reliability of the scoring, the two
assessors both scored a random subset of 205 radiographs
independently. The interobserver reliability for K-L >2 as a
dichotomous variable expressed by the k statistic was as
follows: DIP joints, 0.60; PIP joints, 0.61; MCP joints, 0.63;
and CMC1/TS (base of thumb), 0.74.
Hand pain
The following questions were asked during the home
interview:
N Did you have pain on the right (left) hand during the last
month?
N How long have you had the pain?
The answer to the second question ranged from less than
one month to more than five years.
Hand disability
Stanford health assessment questionnaire (HAQ) was used to
assess disability. Eight questions on the HAQ concerning
hand function were used to assess hand disability (appendix
2). Each question scored from ‘‘no difficulty’’ (0) to ‘‘unable
to do’’ (3). Of the components with more than one question
related to the hand function, the highest score was
considered (as in the original HAQ).14 15 Dependence on
equipment or physical assistance was ignored; this represents
residual disability after compensatory efforts. The scores were
averaged into an overall hand disability score on a scale from
0 (no hand disability) to 3 (hand severely disabled). A mean
score of >0.5 was considered to mean a moderate to severe
hand disability.
Data analysis
Point prevalence of ROA was calculated for each joint, for the
joint groups, and for the whole hand. A rectangle diagram
(Venn diagram with four variables) was used to show the
distribution of ROA in the four hand joint groups.
Univariate and multivariate logistic regression analysis was
used to evaluate the strength of the association of ROA in the
different hand joint groups in each hand and also to examine
associations between ROA and hand pain and/or disability.
The associations are presented as odds ratios (OR) with 95%
confidence intervals (CI) and were adjusted for age and sex.
All analyses were carried out at the level of the person. The
association between ROA and hand pain was evaluated for
each hand separately, while the association with hand
Table 1 Baseline characteristics of the study population
(n = 3906)
Characteristic
Female (%) 58.3
Age (years) (mean (SD)) 66.6 (7.3)
+Hand disability (%) 5.8
++Overall disability index (%) 20.2
Right/left Right Left
*ROA of DIP joints (%) 47.3 38.6 34.8
*ROA of PIP joints (%) 18.2 13.4 11.6
*ROA of MCP joints (%) 8.2 6.1 4.4
*ROA of CMC1/TS (%) 35.8 25.8 30.2
Hand ROA (%) 28.3 21.5 20.6
Hand pain (%) 16.8 14.2 13.5
+Hand disability: mean score of 0.5 or more of various components
composed of eight questions related to hand function on the Stanford
health assessment questionnaire (HAQ).
++Overall disability index: mean score of 0.5 or more on HAQ index
(scored 0 to 3).
*ROA: presence of K-L >2 in at least one joint of the group.
Hand ROA: presence of K-L>2 in two of three groups (DIP, PIP, CMC1/
TS).
CMC1/TS, first carpometacarpal plus trapezioscaphoid (base of thumb);
DIP, distal interphalangeal; K-L, Kellgren–Lawrence radiological grade;
MCP, metacarpophalangeal; PIP, proximal interphalangeal; ROA,
radiographic osteoarthritis.
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Figure 1 Point prevalence of radiographic osteoarthritis (Kellgren–Lawrence radiological grade>2) in the hand joints of men and women (n = 3906).
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disability was evaluated for the presence of ROA in either the
right or the left hand as well as for ROA of the dominant
hand. The association with hand pain and/or disability was
also examined in relation to the number of joints with ROA
(as a continuous variable) and for the more severe forms of
ROA (K-L >3 or K-L = 4).
The SPSS (version 10) program was used for all analyses.
The Span program was used to generate rectangle diagrams.16
RESULTS
In all, we evaluated 3906 participants (53.8% female, 46.2%
male), of mean age 66.6 years (table 1).
Prevalence and pattern of ROA
In all, 61.7% of our study population had K-L >2 in at least
one of the joints of the hand (67% of the women and 54.8%
of the men). DIP joints had the highest frequency (47.3%),
followed by CMC1/TS joints (35.8%), PIP joints (18.2%), and
MCP joints (8.2%) of the right or left hand.
ROA in the separate DIP joints (right hand) occurred in
6.8–17% of men and in 9.7–28.6% of women. The ranges were
3.0% to 5.6% and 4.4% to 7.6% in the PIP joints, 0.2% to 2.2%
and 0.4% to 4.9% in the MCP joints, and 11.4% to 12.0% and
18.8% to 21.2% in the CMC1/TS joints for men and women,
respectively (fig 1).
Except for DIP 2 (right = 23.5%, left = 16.8%), CMC1
(right = 17.2%, left = 21.3%), and TS (right = 15.6%,
left = 17.6%), the other hand joints showed almost the same
frequency in the right and left hands.
Hand ROA was present in 21.5% of right hands and 20.6 of
left hands. The prevalence of ROA increased with age up to 84
years, but decreased in the group aged 85 years and older
(fig 2).
Use of a rectangle diagram showed that ROA in one joint
group more often co-occurred with ROA in other joint groups
in women than in men: DIP joints, 61% (women) v 47%
(men); PIP joints, 91% v 82%; MCP joints, 91% v 77%; CMC1/
TS joints, 68% v 59% (all in the right hand, fig 3). Evaluating
the strength of the relations, the PIP joints and the MCP
joints had the highest odds ratios with ROA of the other joint
groups of the right hand (OR = 9.1 (95% CI, 6.8 to 12.4) and
OR = 5.4 (3.6 to 8.0), respectively). CMC1/TS joints showed
the lowest association with other joint groups of the right
hand (OR = 3.1 (2.6 to 3.6)) (table 2). The left hand showed
similar results.
ROA and hand pain
Prevalence of hand pain (right) was 14.2%; 97% of the
participants suffered from this for longer than one month.
Table 3 shows the association between hand pain and ROA in
the joint groups of the right hand, the strongest being with
the CMC1/TS. Right hand pain showed an association with
ROA of the related hand (OR = 1.9 (95% CI, 1.5 to 2.4)). With
the cut off point at K-L >3 the association was nearly the
same (OR = 1.8 (1.3 to 2.5)), but when the cut off point was
increased to K-L = 4, there was a stronger association with
pain in the right hand (OR = 3.6 (2.2 to 5.8)). Increasing the
number of joints with ROA produced a greater association
with pain (OR = 1.1 (1.1 to 1.2), right hand). Generalised
hand osteoarthritis (ROA of all four joint groups of the
right hand) showed an increased association with hand
pain (OR = 2.7 (1.4 to 5.2)). The associations of hand pain
and ROA in the left hand were similar but are not presented
here.
ROA and hand disability
The prevalence of hand disability was 5.8%. The presence of
hand ROA (right/left) showed an association with hand
disability (OR = 1.5 (1.1 to 2.1)). Specification to the
dominant hand gave nearly the same results. Table 4 shows
the association between hand disability and ROA (right/left)
differentiated for hand joint group; the association was only
significant for the MCP joints (OR = 2.0 (1.3 to 3.0)). The
association of ROA of the base of the thumb became
significant when the analysis was specified to the dominant
hand. However, MCP joints of the dominant hand showed
odds ratios similar to the base of the thumb for hand
disability.
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Figure 2 Age specific point prevalence (%) of osteoarthritis in hand
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Figure 3 Rectangle diagram of radiographic osteoarthritis in the hand
joint groups (n = 3906). The coloured rectangles represent osteoarthritis
(oa) of Kellgren–Lawrence radiological grade >2 in at least one joint
of the group (DIP, PIP, MCP, base) in the right hand for men (top panel)
and women (bottom panel). Base, first carpometacarpal and
trapezioscaphoid joint (thumb base); DIP, distal interphalangeal joint;
MCP, metacarpophalangeal joint; PIP, proximal interphalangeal joint.
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Using the cut off points K-L >3 and K-L = 4 (right/left)
showed nearly the same association with hand disability
(OR = 1.6 (1.1 to 2.5) and OR = 1.6 (0.9 to 2.9), respectively).
An increase in the number of hand joints with ROA showed a
borderline significant association with hand disability. This
association increased to a significant level when the number
of joints with ROA in only the dominant hand was analysed
in relation to hand disability (OR = 1.1 (1.0 to 1.2)).
Generalised hand osteoarthritis (ROA in all four hand joint
groups) also showed a stronger association with hand
disability (OR = 2.7 (1.3 to 6.0)).
DISCUSSION
The results of our study confirm that hand ROA is a common
disease in the elderly, especially in women. It is more likely to
occur in several different hand joint groups simultaneously
than in single joints, the latter being more prevalent in
women than in men. More than 80% of ROA affecting the
PIP and MCP joints co-occurred with the other hand joint
groups. We confirmed a modest association between ROA
and hand pain, the strongest relation being with involvement
of the base of the thumb. Hand disability showed a rather
weak association with ROA, the strongest relation being with
the MCP joints and the base of the thumb.
As the hand joints are small and the features of
osteoarthritis often difficult to define, interpreting the
radiographs of these joints is challenging. However, our
interobserver reliability was good and similar to the results of
other studies.9 17 The predominance given to osteophytes in
the original Kellgren–Lawrence grading scheme has been
discussed previously.18 In the present study we used the
modified definition which defines grade 3 ROA as a
diminution in joint space regardless of whether or not there
are osteophytes. This eliminates the predominance given to
the osteophyte and thus probably provides more valid results.
The definition of hand osteoarthritis (ROA in two of three
hand joint groups) which we used, reported by Hirsch et al,17
does not include the MCP joints. To evaluate whether
including the MCP joints in the definition would change
the association with hand pain or disability we also tested an
alternative definition of hand ROA that included the MCP
joints (ROA in two of four hand joint groups in each hand).
With this alternative definition the results were the same.
In our study, over 55% of the participants had ROA in at
least one hand joint. This means that cartilage degeneration
or subchondral bone reaction is present in at least one joint of
the hand in more than half the open population aged 55 years
and over. This high frequency of ROA, increasing with age
and more frequent in the women, confirms previous
findings.4 12 19 Van Saase4 reported a slight decrease in the
prevalence of ROA in very old people, which was confirmed
in our study in people aged 85 years and over. However, only
47 participants of our study population (1.2%) reached this
age, which may have produced an unstable estimate in this
group. Considering that osteoarthritis is a chronic disease,
another possible explanation is the selection of healthy
survivors or a lower response rate of disabled persons.
The order of involvement of the hand joint groups in our
study was also comparable with other findings. DIP joints
and the base of the thumb were involved most often,
followed by the PIP joints. This was also reported by
Kellgren et al and Egger et al.20 21 The MCP joints had the
lowest frequency in our population, in accordance with
findings of Chaisson et al but in contrast to van Saase et al,
who reported a higher prevalence of ROA in MCP than in PIP
joints.4 Chaisson et al also reported this inconsistency.22
For the first time, we have visualised the pattern of ROA of
the hand joint groups occurring solely or co-occurring with
other joint groups in a rectangle diagram. This shows that the
PIP and MCP joints are more affected concurrently with the
other joint groups and are rarely affected alone. This finding
was confirmed by logistic regression analysis. The base of the
thumb had the lowest odds ratio with the other joint groups.
This supports the view that systemic factors play a more
Table 2 Pattern of radiographic osteoarthritis of the hand joint groups of the right hand
(n = 3906)
Right hand
PIP MCP CMC1/TS Any other joint group
DIP 9.1 (7.1 to 11.7) 3.9 (2.9 to 5.5) 2.9 (2.5 to 3.4) 4.4 (3.7 to 5.0)
PIP 4.7 (3.5 to 6.4) 2.8 (2.3 to 3.5) 9.1 (6.8 to 12.4)
MCP 3.8 (2.9 to 5.2) 5.4 (3.6 to 8.0)
CMC1/TS 3.1 (2.6 to 3.6)
Values are odds ratios and 95% confidence intervals adjusted for age and sex.
CMC1/TS, first carpometacarpal and trapezioscaphoid joint (base of thumb); DIP, distal interphalangeal joint;
MCP, metacarpophalangeal joint; PIP, proximal interphalangeal joint.
Table 3 Association of hand pain with radiographic
osteoarthritis in the hand joint groups (right hand)
Joint group Univariate Multivariate
*DIP 1.5 (1.2 to 1.8) 1.1 (0.9 to 1.4)
*PIP 1.8 (1.4 to 2.3) 1.4 (1.1 to 1.9)
*MCP 1.6 (1.1 to 2.3) 1.2 (0.8 to 1.7)
*CMC1/TS 2.0 (1.6 to 2.4) 1.7 (1.4 to 2.2)
Values are odds ratios (95% confidence intervals) adjusted for age and
sex.
*Presence of Kellgren–Lawrence radiological grade >2 in at least one
joint of the group.
CMC1/TS, first carpometacarpal and trapezioscaphoid joint (base of
thumb); DIP, distal interphalangeal joint; MCP, metacarpophalangeal
joint; PIP, proximal interphalangeal joint.
Table 4 Association of hand disability with radiographic
osteoarthritis in the hand joint groups
Joint group Univariate Multivariate
*DIP 1.3 (0.9 to 1.8) 1.2 (0.8 to 1.7)
*PIP 1.1 (0.8 to 1.7) 0.9 (0.6 to 1.4)
*MCP 2.0 (1.3 to 3.0) 1.8 (1.2 to 2.9)
*CMC1/TS 1.3 (1.0 to 1.9) 1.2 (0.8 to 1.7)
Values are odds ratios (95% confidence intervals) adjusted for age and
sex.
Presence of Kellgren–Lawrence radiological grade >2 in at least one
joint of the group in the right/left hand.
CMC1/TS, first carpometacarpal and trapezioscaphoid joint (base of
thumb); DIP, distal interphalangeal joint; MCP, metacarpophalangeal
joint; PIP, proximal interphalangeal joint.
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important role than physical factors in ROA of the PIP and
MCP joints, but local mechanical factors may play a greater
role in ROA of the base of the thumb.
With regard to the association between a structural marker
of osteoarthritis and its clinical impact, the presence of hand
ROA shows a modest to weak association with clinical
symptoms such as hand pain and/or disability, as reported
previously.9 10 Surprisingly, our analysis in an open popula-
tion gave a similar association of ROA with hand pain or
disability to that reported by Jones et al,10 who analysed a
group of subjects with a diagnosis of hand osteoarthritis. In
addition, we found a dose–response relation with hand pain,
which increased with the number of joints affected by ROA,
with generalised hand ROA (with all four hand joint group
involved), and with the severe form of ROA (Kellgren–
Lawrence grade 4). However, only generalised hand ROA,
and not the severity of Kellgren–Lawrence grade, showed a
significant increase in the association with hand disability.
We examined the relation between hand pain and ROA of
the different hand joint groups and showed that ROA of the
base of the thumb had the strongest association with hand
pain. This supports the hypothesis that ROA of the base of the
thumb has a greater impact on pain than the other hand joint
groups. ROA of the base of the thumb (right or left side) was
less associated with hand disability than ROA of the MCP
joints. However, ROA of the base of the thumb on the
dominant hand had a significant association with hand
disability, similar to that of the MCP group in the dominant
hand. We initially thought that the relation with MCP joint
disease might reflect the presence of another inflammatory
disorder such as rheumatoid arthritis. However, ROA of the
MCP joints was concurrent in more than 80% of cases with
ROA of the other hand joint groups, while it is rare in
rheumatoid arthritis. Thus the result suggests that ROA at
the MCP joints is more disabling than at other sites, or
indicates again that a more generalised form of hand ROA is
more disabling.
This study has several potential limitations. First, it was
primarily designed as a study of determinants and prognosis
of chronic diseases in elderly people and not specifically for
hand disease. Thus we did not have data on the exact location
of hand pain or a pain severity measure. Second, there was
some selection bias in our study population compared with
the total population of the Rotterdam study. We scored
radiographs of 3906 participants including all those available
for follow up six years later. Our study population was
younger, had a smaller proportion of women, and was less
disabled than the total population at baseline. To examine
whether the results of our study can be generalised to the
overall Rotterdam population, we estimated the point
prevalence of hand ROA in the whole of the Rotterdam
study. Adjusted for the different age groups this resulted in
an almost 3% higher estimate. The estimate was almost 2%
higher when adjusted for the severity of general disability.
Thus the point prevalence of ROA shown in our study is
probably somewhat of an underestimate. However, the
prevalence of hand pain was the same for both populations.
The association with hand pain and/or disability might also
be underestimated in our population.
Conclusions
We present extensive data on the prevalence of ROA of hand
joint groups in a large open population of elderly people of
both sexes which will add to the existing knowledge of this
disorder. Our study also showed that the PIP and MCP joint
groups were often affected concurrently with the other joint
groups and rarely alone. Of the separate hand joint groups,
ROA of the thumb base was the main determinant of hand
pain, followed by the PIP joints. Although the DIP joints were
the most affected joints in the hand, ROA in this joint group
seems clinically unimportant. ROA of the MCP joints and the
base of the thumb were both associated with hand disability.
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APPENDIX 1
DEFINITION OF THE KELLGREN–LAWRENCE
RADIOGRAPHIC GRADES
Grade 0, none: no features of osteoarthritis
Grade 1, doubtful: minute osteophyte, doubtful significance
Grade 2, minimal: definite osteophyte, unimpaired joint
space
Grade 3, moderate: diminution of joint space
Grade 4, severe: joint space impaired with sclerosis of
subchondral bone
APPENDIX 2
QUESTIONS ON THE HEALTH ASSESSMENT
QUESTIONNAIRE (HAQ) USED FOR THE HAND
DISABILITY INDEX
Are you able to?
N Dress yourself, including handling of closures?
N Comb your hair or do your own make-up?
N Turn taps on and off?
N Cut your meat, and lift a full cup or glass to your mouth?
N Open a new milk carton?
N Open car doors?
N Hold a pen or a pencil?
N Open jars which have been opened previously?
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Are autoantibodies against a 25-
mer synthetic peptide of M3
muscarinic acetylcholine receptor
a new diagnostic marker for
Sjo¨gren’s syndrome?
We read with great interest the article by
Naito and colleagues,1 who recently proposed
the autoantibodies against M3 muscarinic
acetylcholine receptor (anti-M3R) as a new
diagnostic marker for patients with Sjo¨gren’s
syndrome (SS).
We have been studying anti-M3R recently2
and reviewed some theoretical aspects.3 The
results of our work with the same 25-mer
synthetic peptide (K-R-T-V-P-P-G-E-C-F-I-Q-
F-L-S-E-P-T-I-T-F-G-T-A-I) as used by Naito et
al showed a similar prevalence of anti-M3 in
patients with SS (table 1). Nevertheless, we did
not draw the same conclusions and could not
agree with the statement that antibodies
against the 25-mer synthetic peptide might be
a new diagnostic marker for SS.
We believe that the authors should men-
tion a misleading fact in the article by
Bacman et al,4 which was discussed by
Cavill et al and Dawson et al5 6—namely, the
sequence of 25-mer synthetic peptide used by
Bacman et al was in fact the amino acid
sequence from the second extracellular loop
of M4 muscarinic acetylcholine receptor.
Neither of the two groups were able to detect
the activity of anti-M3R with conventional
immunological approaches. Furthermore,
Gao et al constructed a CHO cell line expres-
sing the human M3R gene and found positive
anti-M3R antibodies in 9/11 patients with SS
and in none of 11 healthy controls.7
The enzyme linked immunosorbent assay
(ELISA) used by Naito et al was somewhat
similar to our procedure. In our ELISA, Costar
medium binding microtitre plates were coated
with the same 25-mer peptide in absolute
ethanol (10 mg/l), and incubated at 4˚ C for at
least 3 hours. Serum samples were first diluted
1:100 in 1% bovine serum albumin (BSA)/
phosphate buffered saline (PBS) (Naito et al
1:50 in 5% BSA/PBS) and incubated for 1 hour
at room temperature (Naito et al for 2 hours at
37˚ C). Optical density values of anti-M3R were
not normally distributed in any of our tested
groups. Therefore, the cut off value was
estimated at the 95th centile of 349 controls.
Neither sensitivity nor specificity of the ELISA
for SS was improved by binding the syn-
thetic peptide to BSA by a cross linker (N-
(c-maleimidobutyryloxy)succinimide ester;
Pierce).
In conclusion, it seems that the 25-mer
synthetic peptide used in routine immunolo-
gical techniques2 5 6 does not disclose clini-
cally relevant antibodies, suggesting that a
short linear peptide does not depict an
adequate epitope for the binding of anti-
M3R. Data presented by Gao et al, applying
native M3R protein, seem far more promis-
ing, but they should be verified on a larger
group of patients and controls.
P Zˇigon, B Bozˇicˇ, S Cˇucˇnik, B Rozman,
M Tomsˇicˇ, T Kveder
University Medical Centre, Department of
Rheumatology, Ljubljana, Slovenia
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Author’s reply
Dr Tanja Kveder et al point out two messages
about our paper.1 Firstly, that our previous
results1 are supported by their further experi-
ments using the same 25-mer synthetic
peptides. Secondly, they suggest that our
statement that antibodies (Abs) to the 25-
mer synthetic peptide might be a new
diagnostic marker for SS is open to criticism.
We agree with Dr Kveder’s comments, in
part, because we did not elucidate the
function of the anti-25-mer synthetic peptide
Abs using M3R transfected cells2 or HSG cell
lines. However, Abs against the second
extracellular portion of M3R are detected in
a subgroup of patients with SS and the
presence of this Ab is significantly associated
with anti-SSB Ab.1 Therefore, we consider
that anti-25-mer synthetic peptide Abs might
be a new diagnostic marker in a subgroup of
patients with SS. Of course, further experi-
ments on the functional analysis using anti-
25-mer synthetic peptide Abs and anti-M3R
protein Abs would be helpful to clarify the
better diagnostic marker in patients with SS.
T Sumida
Department of Internal Medicine, University of
Tsukuba, Tsukuba City, Japan; tsumida@
md.tsukuba.ac.jp
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Short course prednisolone for
adhesive capsulitis
Adhesive capsulitis is a condition whose
pathogenesis remains unclear and for which
there is no consensus about the best medical
treatment.
Writing recently in the Annals, Buchbinder
and her colleagues examined 50 participants
(24 receiving active treatment, 26 placebo)
from community based rheumatology prac-
tices.1 The trial concluded that a ‘‘3 week
course of 30 mg prednisolone daily is of
Table 1 Anti-M3R antibodies in patients with Sjo¨gren’s syndrome (SS), systemic
lupus erythematosus (SLE), and healthy controls (C)
Abs (mOD)
C SS SLE pSS*
(n = 349) (n = 107) (n = 101) (n = 75)
Average 117 179 116 159
Standard deviation 122 266 120 220
Median 88 92 89 81
Maximum 1216 1755 872 1162
Minimum 2 7 2 7
95th Centile 285 635 355 572
Number of positive sera 17 16 6 11
Percent of positive sera 4.8 15.0 5.9 14.7
*pSS, primary SS; SS, primary + secondary SS.
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significant short term benefit in adhesive
capsulitis, but benefits are not maintained
beyond 6 weeks’’.
Although the authors were careful with their
inclusion criteria, they failed to set a cut off
point from the time of onset of pain and
stiffness of the shoulder. Their subjects had a
mean (SD) duration of symptoms of 25.3
(13.2) weeks. This indicates that some of the
participants in this study had had a frozen
shoulder for 38.6 weeks or approximately
9 months. The treatment period was limited
to 3 weeks, regardless of the duration of
symptoms. There were no other interventions.
Other reported studies have also included
patients with long established adhesive cap-
sulitis.2 3 The latter with a mean duration at
presentation of 5.5 months before oral corti-
costeroids were used in a trial.
This study makes an important contribu-
tion to the subject, but the authors make the
point that future research should evaluate
different combinations of treatment and their
optimal duration.
Based on my experience, I support this
recommendation. I have reported the treat-
ment of 30 patients with idiopathic frozen
shoulder (IFS). The mean duration of symp-
toms before referral was 9 weeks. The treat-
ment was with 1–3 intra-articular injections of
betamethasone (Celestone Chronodose) fol-
lowed by oral prednisone 15–20 mg daily,
initially for 2 weeks. A home exercise pro-
gramme was advised. All 30 patients regained
full range ofmovement of the affected shoulder
with freedom from pain and without relapse.4
Future trials should incorporate a treat-
ment group that includes a combination of
oral and intra-articular corticosteroids.
Double blind trials are problematic given
the generally poor outcome for untreated
IFS.5 Patients with frozen shoulder with an
onset greater than 16 weeks should be
excluded from further trials.
IFS is a debilitating condition that is
currently perceived as having a poor prog-
nosis. Although it is not life threatening, it
has a major impact on quality of life. It is
therefore important that rheumatologists
establish best practice for the management
of this condition and educate other medical
practitioners of the value of early, active
treatment in achieving good outcomes.
W A Douglas
201 Wickham Terrace, Brisbane Qld 4000, Australia;
w_b_doug@bigpond.net.au
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Author’s reply
I thank Dr Douglas for his interest
and observations about our trial. He has
documented his positive anecdotal experi-
ence in treating 30 patients with adhesive
capsulitis with a combination of intra-articu-
lar and oral corticosteroids in a brief letter to
the editor.1 Unfortunately, this has not been
published as a full report so no details are
provided. It is not clear whether this was an
open prospective trial or a retrospective chart
review, and, if the latter, whether all patients
with adhesive capsulitis were included in the
review. Similarly, no numerical data are
provided and the time interval between the
1–2 intra-articular steroid injections and the
start of oral prednisone was not reported.
None the less, his claim that all patients fully
recovered, on average 4.5 weeks from initia-
tion of treatment (although no measure of
variance is provided) is noteworthy, lends
broad support to the conclusions of our trial,2
and, we agree, may warrant a formal trial.
We disagree that double blind trials pose a
problem trial in studying adhesive capsulitis,
as this is the best method for minimising bias
in assessment of treatment outcome. Placebo
controlled trials are appropriate when there
are no known effective treatments, and
controlled trials are essential for self limiting
conditions such as adhesive capsulitis. While
we agree that adhesive capsulitis is a painful,
disabling condition, most studies have in fact
established that it has a good prognosis, with
resolution of symptoms in 2–3 years, on
average, in the majority of patients.2
We also disagree with the suggestion that
potential trial participants should be
excluded if symptoms have been present for
longer than 16 weeks. Although we agree
that corticosteroids may be more effective in
the earlier phase of adhesive capsulitis, and
therefore attempting to limit participation in
trials of corticosteroids to those with recent
onset of symptoms may appear to have merit,
early recruitment has proved universally
difficult for trialists in this field.2
Furthermore, our positive trial, which
included participants with an average of 21–
25 weeks of symptoms, provides clear evi-
dence that this constraint is not necessary.
R Buchbinder
Department of Clinical Epidemiology, Cabrini Hospital
and Monash Department of Epidemiology and
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Prevalence and pattern of radiographic
hand osteoarthritis and association with
pain and disability (the Rotterdam
study) (Dahaghin S, Bierma-Zeinstra S M A,
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Figure 3 in this article should have been
published in colour but mistakenly appeared
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Lupus Erythematosus
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This course for 70 young rheumatologists
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in black and white. The correct figure has
now been inserted in the Online version
and subscribers to the journal can see the
amended article at http://ard.bmjjournals.
com/cgi/content/full/64/5/682
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